Nuclear Medicine Residency Research Opportunities

Research Opportunities

Clinical research projects are available in Nuclear Medicine and PET/CT.  Participation in basic research can be accomplished in collaboration with faculty from the Vanderbilt University Institute of Imaging Sciences.

Examples of peer-reviewed articles published by trainees under the mentorship of Nuclear Medicine Faculty are included below. A comprehensive list of our department's publications is also available here.

    1. Shah C, Miller TW, Wyatt SK, et al. Imaging biomarkers predict response to anti-HER2 (ErbB2) therapy in preclinical models of breast cancer. Clin Cancer Res. 2009;15:4712-4721.
    2. Miller TW, Forbes JT, Shah C, et al. Inhibition of mammalian target of rapamycin is required for optimal antitumor effect of HER2 inhibitors against HER2-overexpressing cancer cells. Clin Cancer Res. 2009;15:7266-7276.
    3. Shah C, Patton JA, Sandler MP. How much CT is needed in nuclear medicine. Eur J Nucl Med Mol Imaging. 2008;35:1759-1760.
    4. Manning HC, Merchant NB, Foutch AC, Virostko J, Shah C, et al. Molecular imaging of therapeutic response to epidermal growth factor receptor blockade in colorectal cancer. Clin Cancer Res. 2008;14:7413-7422.
    5. Malkerneker D, Brenner R, Martin WH, Sampson UKA, Feurer I, Kronenberg MW, Delbeke D. CT-based attenuation correction versus prone imaging to decrease equivocal interpretations of rest/stress 99mTc-tetrafosmin SPECT MPI. J Nucl Cardiol 2007, 14:314-323.
    1. Deppen SA, Blume J; Bobbey AJ, Shah C; Graham MM, Lee P, Walker RC. 68Ga-DOTATATE compared to 111In-DTPA-Octreotide for pulmonary and gastroenteropancreatic neuroendocrine tumors: A systematic review and meta-analysis.. J Nucl Med 2016;57: Jan 14 online. 
    2. Ayres KL, Spottswood S, Delbeke D, Price, R, Hodges P, Wang L, Martin WH. Dose Reduction in Pediatric Bone Scintigraphy: Validation of the 2010 North American Consensus Guidelines. J Nucl Med 2015;56 (9): 1391-1394.
    3. Ayres K, Mayer I, Delbeke D, Manning C. 18F-FES, a novel isotope for breast cancer PET/CT imaging: Early pharmacodynamics experience in patients on ARN810. Vanderbilt Research Forum, April 2014.
    4. Rhodes MM, Delbeke D, Whitlock JA, Martin WH, Kuttesch JF, Frangoul HA, Shankar S. Utility of FDG-PET/CT in follow-up of children treated for Hodgkin’s and non-Hodgkin’s lymphoma. J Pediatr Hematol Oncol 2006;28:300-306.
    1. Agrawal V, Hosey C, Smith GT, Shah C. Detrimental effects of nitroglycerin use during regadenoson vasodilator stress testing: A cautionary tale. J Nucl Cardiol. 2018;25:1718-1723.
    1. Anderson CA, Rice MH, Pinson CW, Chapman WC, Ravi RS, Delbeke D. FDG PET imaging in the evaluation of gallbladder carcinoma and cholangiocarcinoma. J. Gastrointest Surg 2004;8 (1):90-97.
    2. Wudel LJ, Delbeke D, Morris D, Rice MH, Washington MK, Pinson CW, Chapman WC. The role of FDG-PET imaging in the evaluation of hepatocellular carcinoma. Amer Surg 2003;69:117-126.
    1. Cerci JJ, Linardi CC, Pracchia LF, Junior JS, Trindade E, Delbeke D, Cerci RJ, Carr R, Meneghetti JC, Buccheri V. 3. 2-[18F]-fluoro-2-desoxy-D-glucose positron emission tomography initial staging impacts on survival in Hodgkin lymphoma. World J Radiol. 2013 Dec 28;5(12):484-90.
    2. Cerci MS, Cerci JJ, Cerci RJ, Pereira Neto CC, Trindade E, Delbeke D, da Cunha CL, Vitola JV. Myocardial perfusion imaging is a strong predictor of death in women. JACC Cardiovasc Imaging. 2011 Aug;4(8):314-320.
    3. Cerci JJ; Trindade E; Buccheri V; Fanti S; Coutinho AMN; Zanoni L; Linardi CCG; Celli M; Delbeke D; Pracchia LF; Pitela FA; Soares J; Zinzani PL; Meneghetti JC. Consistency of FDG-PET accuracy and cost-effectiveness in initial staging of patients with Hodgkin lymphoma across juridictions. Clinical Lymphoma, Myeloma & Leukemia 2011;11 (4): 314-320.
    4. Cerci JJ, Pracchia LF,  Linardi CC, Pitella FA, Delbeke D, Izaki M, Trindade E, Soares J Jr, Buccheri V, Meneghetti JC. 18F-FDG PET After 2 Cycles of ABVD Predicts Event-Free Survival in Early and Advanced Hodgkin Lymphoma. J Nucl Med 2010;51(9):1337-1343.
    5. Cerci JJ, Trindade E, Pracchia LF, Pitella FA, Linardi CC, Soares J Jr, Delbeke D, Topfer LA, Buccheri V, Meneghetti JC. Cost effectiveness of positron emission tomography in Hodgkin’s lymphoma patients in unconfirmed complete response or partial remission after first line therapy. J Clin Oncol 2010;28 (8):1415-21.
    1. Spratt DE, Diaz R, McElmurray J, Duggan D, Lu B, Delbeke D. Impact of FDG PET/CT on delineation of gross tumor volume (GTV) for radiation planning in non small cell lung cancer (NSCLC). Clin Nucl Med 2010;35 (4):237-243.